NIAID conducts and supports basic research to better understand viruses, bacteria, and other infectious agents that cause diseases of public health concern. This research provides the foundation for developing medical products and strategies to diagnose, treat, and prevent a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism.
Media Availability: Antiviral Favipiravir Successfully Treats Lassa Virus in Guinea Pigs—Oct. 13, 2015
VSV-based Nipah Virus Vaccine Fully Protects African Green Monkeys—June 12, 2015
Ciprofloxacin Licensed to Treat Pneumonic Plague—May 20, 2015
Experimental Ebola Vaccine Safe, Prompts Immune Response—April 1, 2015
All Biodefense and Emerging Infectious Diseases News and Events
Last Updated October 27, 2015